Dr. Assi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
830 Harrison Ave 3rd FL
Moakley Hematologyoncology
Boston, MA 02118Phone+1 617-638-6428Fax+1 617-638-5756
Education & Training
University of Oklahoma Health Sciences CenterFellowship, Hematology and Medical Oncology, 2017 - 2020
Albany Medical CenterResidency, Internal Medicine, 2017
American University of Beirut Faculty of MedicineClass of 2011
Certifications & Licensure
NJ State Medical License 1988 - Present
MA State Medical License 2020 - 2025
OK State Medical License 2017 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 3 citationsPrognostic and Predictive Biomarkers for Pancreatic Neuroendocrine Tumors.Wenzel M Hackeng, Hussein A Assi, Florine H M Westerbeke, Lodewijk A A Brosens, Christopher M Heaphy
Surgical Pathology Clinics. 2022-09-01 - 4 citationsRapid Progression After 177Lu-DOTATATE in Patients With Neuroendocrine Tumors.Hussein A. Assi, Kathleen Hornbacker, Shagufta Shaheen, Theresa Wittenberg, Robyn Silberman
Pancreas. 2021-07-01 - 1 citationsLong-Term Survival With Nanoliposomal Irinotecan in Pancreatic Cancer.Hussein A. Assi, Sufana Shikdar, Laith Alhyari, Raid Aljumaily
Pancreas. 2020-10-01
Press Mentions
'A Position of Despair and Anger': What We Heard This WeekOctober 12th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
